'Toxicity map' of brain may help protect cognition for cancer patients
New research from Wake Forest Baptist Medical Center is giving radiation oncologists who treat brain tumors a better understanding of how to preserve the brain's functions while still killing cancer.
Cancer
Mar 20, 2013 |
4 / 5 (2) |
0
Promising new drug treats and protects against radiotherapy-associated oral mucositis
Mouse model studies show that administered genetically or topically, protein Smad7 protects against or heals mouth sores commonly associated with cancer treatment.
Cancer
Mar 12, 2013 |
not rated yet |
0
|
American Academy of Microbiology releases resistance report
What do cancer cells, weeds, and pathogens have in common? They all evolve resistance to the treatments that are supposed to eliminate them. However, researchers developing the next generation of antibiotics, herbicides, ...
Other
Mar 07, 2013 |
not rated yet |
0
Chemo given into the abdomen could boost ovarian cancer survival
Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer.
Cancer
Mar 06, 2013 |
not rated yet |
0
The right dose for oncology
EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.
Cancer
Mar 04, 2013 |
2 / 5 (2) |
0
Researchers discover breakthrough in ovarian cancer
Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...
Cancer
Feb 14, 2013 |
5 / 5 (3) |
0
|
Researchers discover biological diversity in triple-negative breast cancer
Triple-negative breast cancers are more biologically diverse than previously believed and classification should be expanded to reflect this heterogeneity, according to University of North Carolina researchers.
Cancer
Feb 13, 2013 |
not rated yet |
0
|
Could duration of prostate cancer hormone therapy be halved?
(HealthDay)—For some men with prostate cancer, hormonal therapy to beat the disease could be safely cut from three years to half that time, a new clinical trial suggests.
Cancer
Feb 13, 2013 |
5 / 5 (1) |
0
|
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets
An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Contrary to expectations, the scientists found relatively few recurrent gene ...
Genetics
Jan 20, 2013 |
5 / 5 (2) |
0
|
Research makes connetion between tubal ligation and increase in cervical cancer rates
the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included ...
Cancer
Jan 14, 2013 |
not rated yet |
0
Sickle cells show potential to attack aggressive cancer tumors
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed ...
Cancer
Jan 09, 2013 |
5 / 5 (4) |
0
|
E-mail prompts improve code status documentation
(HealthDay)—For patients with advanced lung cancer, prompting oncologists via e-mail successfully improved both the rate and timing of outpatient code status documentation in patients' electronic health ...
Cancer
Jan 05, 2013 |
not rated yet |
0
Some men voice complaints of shortened penis following prostate cancer treatment
A small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, with some saying that it interfered with intimate relationships and caused them to regret the type of treatment ...
Cancer
Jan 02, 2013 |
not rated yet |
0
Administering chemo ups income for non-salaried oncologists
(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published ...
Cancer
Jan 02, 2013 |
not rated yet |
0
